Radnostix Scraps Plant Sale, Bets on Nuclear Resurgence

IDAHO FALLS, ID – March 16, 2026 – In a dramatic reversal, Radnostix, Inc. has terminated a multi-million dollar agreement to sell its depleted uranium deconversion facility, opting instead to retain the asset amidst what its leadership calls a global “resurgence” in nuclear energy. The mutual termination of the $12.45 million deal with American Fuel Resources, LLC (AFR) came after the buyer failed to secure the necessary funding, forcing a strategic pivot that leaves Radnostix with short-term financial gaps but a potentially more valuable long-term asset.

The deal, originally signed in February 2024, would have transferred the company’s depleted uranium deconversion and fluorine extraction plant (the “DUF6 Plant”) to AFR. However, with the March 31, 2026 closing deadline looming, AFR requested a one-year extension, citing an inability to make the final payment. Radnostix, expressing “low confidence” that AFR could secure funding even with an extension, agreed to terminate the agreement, effectively placing a bet on the appreciating value of its own nuclear assets.

A Deal Undone at the Finish Line

The collapse of the Asset Purchase Agreement (APA) is particularly striking given how close the deal was to completion. Both parties had navigated the complex regulatory maze and were, according to the company, “on the cusp of receiving U.S. Nuclear Regulatory Commission (the ‘NRC’) consent to transfer” the plant’s license. This final-stage withdrawal underscores the significant financial hurdles that ultimately proved insurmountable for the buyer.

American Fuel Resources, LLC had already invested $170,000 in non-refundable payments—a $50,000 prepayment and $120,000 in fees to extend the NRC review process—but was unable to produce the final $12,450,000 required at closing. The mutual decision to terminate the APA and withdraw the NRC application brings an end to a two-year process, forcing Radnostix to re-evaluate its strategy for the specialized facility.

In a statement, Radnostix CEO Shahe Bagerdjian framed the termination as a strategic opportunity. “I want to thank AFR for their persistence and efforts in trying to close this deal and their transparency at the end,” he said, adding, “We look forward to exploring all our options for the DUF6 assets over the coming months.”

A Strategic Pivot Amid a Nuclear Renaissance

Radnostix’s decision to retain the DUF6 plant is anchored in a firm belief that the asset’s value has significantly increased since the APA was first signed. Bagerdjian pointed to a “resurgence in large scale nuclear energy projects, including several domestic uranium enrichment initiatives,” as the primary driver behind this re-evaluation. This sentiment reflects a broader global trend where concerns over energy security and climate change are pushing nations to reconsider nuclear power as a stable, carbon-free energy source.

Depleted uranium hexafluoride (DUF6) is a byproduct of the uranium enrichment process. For decades, it was largely considered nuclear waste. However, deconversion plants like the one owned by Radnostix can process DUF6 to extract valuable fluorine for industrial applications and convert the remaining uranium into a more stable oxide form. This oxide can be safely stored or potentially used as a fuel component in next-generation advanced reactors, such as fast reactors.

The growing interest in Small Modular Reactors (SMRs) and a renewed focus on strengthening domestic nuclear fuel supply chains, particularly in the United States, have turned assets like the DUF6 plant from liabilities into potentially lucrative components of the energy infrastructure. As more uranium is enriched to meet rising demand, the need for efficient DUF6 deconversion services is expected to grow, positioning Radnostix’s plant as a key strategic asset.

The Financial Fallout and Future Options

While the long-term outlook may be bright, the immediate financial impact on Radnostix is stark. The company will not receive the anticipated $12.45 million cash infusion. As a result, plans to use those proceeds to pay down various long-term notes are now on hold, a significant setback for a company with a debt-to-equity ratio of 1.16. The termination negates all previously disclosed financial benefits of the sale, including a recognized gain on assets and improvements to cash flow and operating costs, as noted in its Q3 2025 filings.

Those same filings paint a picture of a company facing financial pressures, having reported a net loss of $477,080 for the first nine months of 2025. The Fluorine Products segment, which includes the DUF6 plant, generated no revenue during that period but incurred over $82,000 in maintenance expenses. The company is also managing the financial impact of a separate, unrelated product recall expected to cost over $150,000 in write-offs and refunds through early 2026.

Despite these challenges, Radnostix is now free to “evaluate all possible options” for the DUF6 assets. These alternatives could include:

• Seeking a New, Better-Funded Buyer: With the nuclear market heating up, Radnostix could attract a larger, more established player in the energy or chemical sectors willing to pay a premium for a deconversion facility with a nearly-approved license transfer.
• Forming a Joint Venture: The company could partner with another firm that has the capital and operational expertise to bring the plant online, allowing Radnostix to retain a stake in its future profitability without bearing all the costs and risks.
• Holding the Asset: Radnostix might choose to hold the plant, continuing to maintain it while waiting for market conditions to improve even further, thereby maximizing its eventual sale price or operational value.

The Regulatory Gauntlet

The failed deal serves as a potent reminder of the immense complexity involved in transferring nuclear assets. The fact that Radnostix and AFR were in the final stages of the NRC consent process highlights the extensive due diligence required. Any transfer of a nuclear facility demands a rigorous review of the buyer's financial stability, technical qualifications, and security plans to ensure the safe handling of radioactive materials and long-term management of decommissioning liabilities.

Navigating the web of regulations from the NRC and the Environmental Protection Agency (EPA) is a capital-intensive and time-consuming endeavor. The collapse of the deal due to financing issues, after most of the regulatory hurdles were cleared, illustrates why the nuclear industry has such high barriers to entry. Any future transaction for the DUF6 plant will require a buyer with not only a strategic vision but also exceptionally deep pockets and a proven ability to satisfy regulators. For Radnostix, this failed sale has become an expensive but valuable lesson, sharpening its focus on finding a partner whose financial strength matches the strategic value of the asset.